Our result was consistent with the studies that bone marrow-derived MSCs (BM-MSCs) promoted colorectal cancer progression through paracrine neuregulin 1/HER3 signalling [32] and tumor formation of multiple myeloma by cytokine IL-6 which was delivered via MSC-derived exosomes [33]. This evidence concerns the gene ERBB3 and plasma cell myeloma.